NOUVEAU POLYMORPHE CRISTALLIN DU 6-OXO+6,7,8,9,10,11-HEXAHYDROCYCLOHEPTA°C!CHROMEN-3-YL SULFAMATE

Polymorph of 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate (I) having a X-ray powder diffraction as given in the specification, crystalline dimethyl sulfoxide solvate of (I) and crystalline 1, 4-dioxane hemisolvate of (I), are new. An independent claim is included for the preparat...

Full description

Saved in:
Bibliographic Details
Main Authors MONDOLY NATHALIE, POIROT BERTRAND, DELAHAYE DELPHINE, DIANCOURT FRANCIS, HOUSSIN OPHELIE, COQUEREL GERARD, ROLLAND ALAIN, PETIT MARIE NOELLE, BROCHARD ANNE, MARTINS DAMIEN, DIOLEZ CHRISTIAN
Format Patent
LanguageFrench
Published 25.02.2011
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Polymorph of 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate (I) having a X-ray powder diffraction as given in the specification, crystalline dimethyl sulfoxide solvate of (I) and crystalline 1, 4-dioxane hemisolvate of (I), are new. An independent claim is included for the preparation of the compounds. ACTIVITY : Cytostatic. MECHANISM OF ACTION : Steroid sulfatase inhibitor.
Bibliography:Application Number: FR20090000656